Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 27

1.

Evaluation of Polygenic Determinants of Non-Alcoholic Fatty Liver Disease (NAFLD) By a Candidate Genes Resequencing Strategy.

Di Costanzo A, Belardinilli F, Bailetti D, Sponziello M, D'Erasmo L, Polimeni L, Baratta F, Pastori D, Ceci F, Montali A, Girelli G, De Masi B, Angeloni A, Giannini G, Del Ben M, Angelico F, Arca M.

Sci Rep. 2018 Feb 27;8(1):3702. doi: 10.1038/s41598-018-21939-0.

2.

Overexpression of the Vitronectin V10 Subunit in Patients with Nonalcoholic Steatohepatitis: Implications for Noninvasive Diagnosis of NASH.

Del Ben M, Overi D, Polimeni L, Carpino G, Labbadia G, Baratta F, Pastori D, Noce V, Gaudio E, Angelico F, Mancone C.

Int J Mol Sci. 2018 Feb 18;19(2). pii: E603. doi: 10.3390/ijms19020603.

3.

PNPLA3 variant and portal/periportal histological pattern in patients with biopsy-proven non-alcoholic fatty liver disease: a possible role for oxidative stress.

Carpino G, Pastori D, Baratta F, Overi D, Labbadia G, Polimeni L, Di Costanzo A, Pannitteri G, Carnevale R, Del Ben M, Arca M, Violi F, Angelico F, Gaudio E.

Sci Rep. 2017 Nov 17;7(1):15756. doi: 10.1038/s41598-017-15943-z.

4.

Adherence to Mediterranean Diet and Non-Alcoholic Fatty Liver Disease: Effect on Insulin Resistance.

Baratta F, Pastori D, Polimeni L, Bucci T, Ceci F, Calabrese C, Ernesti I, Pannitteri G, Violi F, Angelico F, Del Ben M.

Am J Gastroenterol. 2017 Dec;112(12):1832-1839. doi: 10.1038/ajg.2017.371. Epub 2017 Oct 24.

PMID:
29063908
5.

Spleen dimensions are inversely associated with lysosomal acid lipase activity in patients with non-alcoholic fatty liver disease.

Polimeni L, Pastori D, Baratta F, Tozzi G, Novo M, Vicinanza R, Troisi G, Pannitteri G, Ceci F, Scardella L, Violi F, Angelico F, Del Ben M.

Intern Emerg Med. 2017 Dec;12(8):1159-1165. doi: 10.1007/s11739-017-1746-1. Epub 2017 Sep 12.

PMID:
28900817
6.

Severe reduction of blood lysosomal acid lipase activity in cryptogenic cirrhosis: A nationwide multicentre cohort study.

Angelico F, Corradini SG, Pastori D, Fargion S, Fracanzani AL, Angelico M, Bolondi L, Tozzi G, Pujatti PL, Labbadia G, Corazza GR, Averna M, Perticone F, Croce G, Persico M, Bucci T, Baratta F, Polimeni L, Del Ben M, Violi F; LAL-Cirrhosis Collaborative Research Group.

Atherosclerosis. 2017 Jul;262:179-184. doi: 10.1016/j.atherosclerosis.2017.03.038. Epub 2017 Mar 31.

PMID:
28396038
7.

Non-alcoholic fatty liver disease and subclinical atherosclerosis: A comparison of metabolically- versus genetically-driven excess fat hepatic storage.

Di Costanzo A, D'Erasmo L, Polimeni L, Baratta F, Coletta P, Di Martino M, Loffredo L, Perri L, Ceci F, Montali A, Girelli G, De Masi B, Angeloni A, Catalano C, Maranghi M, Del Ben M, Angelico F, Arca M.

Atherosclerosis. 2017 Feb;257:232-239. doi: 10.1016/j.atherosclerosis.2016.12.018. Epub 2016 Dec 21.

PMID:
28027788
8.

Phenotypical heterogeneity linked to adipose tissue dysfunction in patients with Type 2 diabetes.

Barchetta I, Angelico F, Del Ben M, Di Martino M, Cimini FA, Bertoccini L, Polimeni L, Catalano C, Fraioli A, Del Vescovo R, Morini S, Baroni MG, Cavallo MG.

Clin Sci (Lond). 2016 Oct 1;130(19):1753-62. doi: 10.1042/CS20160348. Epub 2016 Jul 25.

PMID:
27458255
9.

The role of nutraceuticals for the treatment of non-alcoholic fatty liver disease.

Del Ben M, Polimeni L, Baratta F, Pastori D, Angelico F.

Br J Clin Pharmacol. 2017 Jan;83(1):88-95. doi: 10.1111/bcp.12899. Epub 2016 Mar 4. Review.

10.

Does Lysosomial Acid Lipase Reduction Play a Role in Adult Non-Alcoholic Fatty Liver Disease?

Baratta F, Pastori D, Polimeni L, Tozzi G, Violi F, Angelico F, Del Ben M.

Int J Mol Sci. 2015 Nov 25;16(12):28014-21. doi: 10.3390/ijms161226085. Review.

11.

Similar Reduction of Cholesterol-Adjusted Vitamin E Serum Levels in Simple Steatosis and Non-Alcoholic Steatohepatitis.

Pastori D, Baratta F, Carnevale R, Cangemi R, Del Ben M, Bucci T, Polimeni L, Labbadia G, Nocella C, Scardella L, Pani A, Pignatelli P, Violi F, Angelico F.

Clin Transl Gastroenterol. 2015 Oct 1;6:e113. doi: 10.1038/ctg.2015.43.

12.

Reduced Lysosomal Acid Lipase Activity in Adult Patients With Non-alcoholic Fatty Liver Disease.

Baratta F, Pastori D, Del Ben M, Polimeni L, Labbadia G, Di Santo S, Piemonte F, Tozzi G, Violi F, Angelico F.

EBioMedicine. 2015 May 22;2(7):750-4. doi: 10.1016/j.ebiom.2015.05.018. eCollection 2015 Jul.

13.

Oxidative stress: New insights on the association of non-alcoholic fatty liver disease and atherosclerosis.

Polimeni L, Del Ben M, Baratta F, Perri L, Albanese F, Pastori D, Violi F, Angelico F.

World J Hepatol. 2015 Jun 8;7(10):1325-36. doi: 10.4254/wjh.v7.i10.1325. Review.

14.

Relation of nonalcoholic fatty liver disease and Framingham Risk Score to flow-mediated dilation in patients with cardiometabolic risk factors.

Pastori D, Loffredo L, Perri L, Baratta F, Scardella L, Polimeni L, Pani A, Brancorsini M, Albanese F, Catasca E, Del Ben M, Violi F, Angelico F.

Am J Cardiol. 2015 May 15;115(10):1402-6. doi: 10.1016/j.amjcard.2015.02.032. Epub 2015 Feb 19.

PMID:
25776455
15.

Relationship between carotid intima-media thickness and non valvular atrial fibrillation type.

Proietti M, Calvieri C, Malatino L, Signorelli S, Corazza GR, Perticone F, Vestri AR, Loffredo L, Davì G, Violi F, Basili S; ARAPACIS (Atrial Fibrillation Registry for Ankle-Brachial Index Prevalence Assessment-Collaborative Italian Study) STUDY Investigators.

Atherosclerosis. 2015 Feb;238(2):350-5. doi: 10.1016/j.atherosclerosis.2014.12.022. Epub 2014 Dec 20.

PMID:
25555267
16.

Erratum to: medication prescription and adherence disparities in non valvular atrial fibrillation patients: an Italian portrait from the ARAPACIS study.

Raparelli V, Proietti M, Buttà C, Di Giosia P, Sirico D, Gobbi P, Corrao S, Davì G, Vestri AR, Perticone F, Corazza GR, Violi F, Basili S; ARAPACIS Study Investigators; GIS Group.

Intern Emerg Med. 2015 Mar;10(2):261-5. doi: 10.1007/s11739-014-1166-4. No abstract available.

PMID:
25519853
17.

The efficacy and safety of statins for the treatment of non-alcoholic fatty liver disease.

Pastori D, Polimeni L, Baratta F, Pani A, Del Ben M, Angelico F.

Dig Liver Dis. 2015 Jan;47(1):4-11. doi: 10.1016/j.dld.2014.07.170. Epub 2014 Sep 16. Review.

18.

Modern approach to the clinical management of non-alcoholic fatty liver disease.

Del Ben M, Polimeni L, Baratta F, Pastori D, Loffredo L, Angelico F.

World J Gastroenterol. 2014 Jul 14;20(26):8341-50. doi: 10.3748/wjg.v20.i26.8341. Review.

19.

NOX2-generated oxidative stress is associated with severity of ultrasound liver steatosis in patients with non-alcoholic fatty liver disease.

Del Ben M, Polimeni L, Carnevale R, Bartimoccia S, Nocella C, Baratta F, Loffredo L, Pignatelli P, Violi F, Angelico F.

BMC Gastroenterol. 2014 Apr 23;14:81. doi: 10.1186/1471-230X-14-81.

20.

Prevalence of peripheral artery disease by abnormal ankle-brachial index in atrial fibrillation: implications for risk and therapy.

Violi F, Daví G, Hiatt W, Lip GY, Corazza GR, Perticone F, Proietti M, Pignatelli P, Vestri AR, Basili S; ARAPACIS Study Investigators.

J Am Coll Cardiol. 2013 Dec 10;62(23):2255-6. doi: 10.1016/j.jacc.2013.07.035. Epub 2013 Aug 14. No abstract available.

Supplemental Content

Loading ...
Support Center